It is well recognized that growth hormone (GH) may act as a growth and differentiation factor for the thymus gland. Recently, it has been reported that Pit-1IGHF-1 t k ption factor, which controls the expression of both GH and prolactin, is expressed in stromal (not lymphoid) cells of human thymus. Here, we demonstrated by immunohistochemistry and in situ hybridization the presence of distinct GHproducing epithelial cell subsets in human thymus. The cells positive for GH mRNA and GH-immunoreactive substance Supported in part by grants (60% and 40%) from MURST. are both located in the same thymus compartments, i.e., along the thymus capsule, in the subcapsular cortex, and within the septa. Local concentration of GH higher than systemic ones, in combination with other factors, may be important in regulating the thymic mictoenvirOnment necessary for T-lymphocyte differentiation. (]Histochem Cyto-&em 1994) 
Introduction
It is well recognized that growth hormone (GH) may act as a growth and differentiation factor in the hematopoietic system (1,2). It has been found that mice injected with antiserum to GH develop thymic atrophy (I), and the thymic involution that occurs during aging can be reversed by injections of GH (1) . Clinical studies performed to date do not offer strong support for pituitary involvement in immune function. This could be due to the fact that a number of immunological studies have examined patients suffering from pituitary dwarfism instead of patients who underwent hypophysectomy (2). Another possibility is that some immune functions are regulated by locally produced GH rather than by GH derived from the hypophysis.
Recently, we have observed that GH at physiological concentrations stimulates both spontaneous and epithelium-triggered human thymocyte proliferation in vitro, probably through the induction of insulin-like growth factor I (3). Moreover, these two hormones enhance the adhesion of thymocytes to cultured thymic epithelial cell surfaces and increase the percentage of CD4-positive cells among the adherent thymocytes (3).
We found that human thymic subcortical and perivascular epithelial cells contain immunoreactive-like GH. Because resting mononuclear leukocytes isolated from thymus and other lymphoid organs have the ability to synthesize the release GH (I), it is possible that thymic epithelial cells either produce GH or simply take it up.
Recently, it has been reported that the Pit-UGHFI transcription factor is expressed in stromal (not lymphoid) cells of human thymus (4). However, Pit-I/GHF-1 controls the expression of both GH and prolactin (PRL). To ascertain whether thymic epithelial cells synthesize GH, we analyzed human thymuses using both immunohistochemistry for GH and in situ hybridization for GH mRNA.
Materials and Methods
Tissue. Fragments derived from four thymus glands obtained from 1 month-to 4-par-old children during open-heart surgery were snap-frozen in liquid nitrogen and stored at -70'C until used or were immediately processed for immunohistochemical and electron microscopy analyses. Single cell supensions of thym~c lymphocytes were prepared as previody reported (5).
In Situ Hybridization. Cryostat sections 6 Mm thick were cut and collected on glass slides coated with 0.1% poly-L-lysine (Sigma; St Louis, MO) (6). After drying, sections were immersed for 10 min in Lo's fimtive (0.08% formaldehyde, 5 % acetic acid in 0.25 M NaCI). Then the slides were rinsed twice for 15 min in PBS, immersed for 10 min in PBS containing 0.2% glycine (wlv), and washed for 15 min in PBS. All the buffers and glassware MAGGIANO, PIANTELLI, RICCI, LAROCCA, CAPELLI, RANELLMTI used for the detection of mRNA were RNAse-free. Procedures were performed as described by Garson et al. (7) , with minor modifications. Specimens were incubated with 1 mglml proteinase K (Sigma) in PBS containing 5 mM EDTA for 10 min at 37°C. After washing in double-strength standard saline citrate (2 x SSC), slides were incubated with RNAse-free DNAse (100 mglml 2 x SSC) for 60 min at 37°C in a humidified box, rinsed twice in 2 x SSC, dehydrated through an ethanol gradient series, and air-dried.
pHGH 107 probe (ATCC; Rockville, MD) including a cDNA insert of human growth hormone, in a pBR 322 vector modified by the insertion of two lac LJV5 promoters at the EcoRI site, was used as a whole plasmid and labeled according to the manufacturer's manual (DNA Labeling and Detection Kit; Boehringer, Mannheim. Germany) with digcmigenin as previously reported (8). Digoxigenin-labeled probe (10 ng120 ml of hybridization buffer), prepared according to Garson et al. (9) . was placed on each slide and covered with a glass coverslip. Coverslips were sealed with rubber cement and both tissue and DNA probe were denatured in an oven at 80'C for 10 min. Incubation was then performed at 42'C overnight for [16] [17] [18] hr in a waterbath. After hybridization the coverslips were removed and the slides were sequentially washed for 30 min in 2 x SSC at room temperature (RT), for 30 min in 0.1 x SSC at 42'C, and for 15 min in 2 x SSC at RT. Slides reacted with digoxigenin-labeled probe were washed for 10 min at RT in Tris-HCI 100 mM, NaCl 150 mu, pH 7.5 (washing buffer), and incubated with 0.5% (w/v) blocking reagent (Boehringer) in washing buffer and then rinsed twice in the same buffer. Slides were then incubated for 2 hr with anti-digoxigenin alkaline phosphatase-conjugated antibody (150 mUlml) at RT in the dark. After two washes with washing buffer, slides were briefly treated with a solution containing 100 mM Pis-HC1, 100 mM NaCI, 50 mM MgC12, pH 9.5, and incubated in a humidified box for 2 hr with a solution of nitroblue tetrazolium salt (0.34 mglml) and 5-bromo-4-chloro-3-indolyl phosphate (0.18 mglml) containing 0.25 mglml levamisole, at RT in darkness. The staining reaction was stopped with 10 mM Tris-HC1, 1 mM EDTA, pH 8, buffer. The specimens were counterstained with Gill's hematoxylin, mounted with Kaisergelatine (Merck; Darmstadt, Germany), and observed with an optical microscope (kuioskop-Zek, Oberkochen, Germany). In control experiments, tissue samples hybridized with digoxigenin-labeled pBR 322 or pBR 328 vectors did not display any signal. Moreover. in control samples, digoxigenin-labeled pHGH 107 DNA signals were inhibited by addition of homologous unlabeled pHGH 107 DNA. After tissue fixation, some sections were pre-treated for 60 m h with 100 mg/ml RNAse A (Sigma) in 2 x SSC. After enzyme pre-treatment, the sections were rinsed three times with 2 x SSC and then used for hybridization with the probe. A significant loss of signal after RNA% treatment indicated that the probe was hybridizing to RNA. Immunohistochemical Analysis. Thymus samples were processed as previously described (3.10). Briefly, frozen sections were treated with 0.03% (vlv) H202 in absolute methanol to block endogenous peroxidase activity and incubated for 1 hr with rabbit anti-human G H polyclonal antibody (UCB Bioproducts; O h , Belgium) at dilutions ranging from 1:200 to 1400.
At these dilutions the antibody did not crossreact with human LH. TSH, LHa, FSH. PRL. or ACTH, as assessed by competition analysis. Indirect immunostaining was achieved using both PAP (Dako; Copenhagen, Denmark) (11) and ABC (Vector; Burlington, MA) (12) techniques. The peroxidase was developed with 3-amino-9-ethyl-carbazole (13) or with 3,3'diaminobenzidine tetrahydrochloride in 0.05 M Tris-HCI buffer containing 0.01% (vlv) H202. The specificity of immunolabeling was tested by prc-absorbing antiserum with its homologous synthetic antigen (loo-fold weight excess) (UCB Bioproducts). After this procedure, the immunoreac-tion was abolished. The positive control for GH consisted of a human GHsecreting adenoma. Negative controls were performed using normal rabbit serum or anti-thyroglobulin rabbit antibodies (Ylem; Avczzano. Italy) instead of the primary antiserum, or by omitting either the second antiscrum or the PAP or ABC complex.
Immunoelmron Microscopy. Procedures were done as previously  reported (14.15) . Bridly, small thymus fragments were cut on a S o d l TC-2 sectioner. fixed in 4% paraformaldehyde for 2 hr, and processed by the PAP method. using anti-GH antibody. After immunoreaction. the slices were post-fixed in 1% OsO4 in 0.1 M PBS for 30 min. dehydrated in ethanol, and embedded in Epon 812. Sections were lightly counterstained with lead citrate and observed with a Philips EM 400 microscope. 
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Results
All thymuses studied showed a normal histology for the respective age. In the sections stained with the anti-GH antibody, a rim of immunoreactive cells was observed along the thymus capsule and subcapsular cortex ( Figure 1A) and septa ( Figure 1B) . A few individual scattered positive cells were also found in the remaining cortex. The immunolabeled cells were irregular in shape, with palestaining nuclei and cytoplasmic projections containing the anti-GH antibody immunoreactive materials ( Figure 1B) . Thymic lymphocytes were apparently non-reactive both in situ (Figure 1) and in suspensions obtained from normal thymus (not shown).
Immunoelecuon microscopic studies were carried out to better characterize the immunoreactive cells. The immunolabeled cells appeared morphologically heterogeneous and could be classified according to the criteria reported by van de Wijngaert et al. (16) .
GH-immunoreaCtiVe cells located beneath the capsule weze ovoid in shape, with the major axis parallel to the thymic surface ( Figure  2A) . These cells contained abundant rough endoplasmic reticulum (rER) and heterochromatic nuclei, and were recognizable by the above features as Type 1 cells. GH-immunoreactive cells present along the septa in the perivascular spaces were irregular in shape, with heterochromatic nuclei and evident nucleoli. Furthermore, they contained abundant rER and could be classified as Type 1 cells ( Figure 2B ). GH-immunoreactive cells located in the subcapsular cortex were found to give off long, slender cytoplasmic processes embracing adjacent thymocytes. These cells were either Type 2 cells displaying "pale" round euchromatic nuclei and long cytoplasmic processes (Figures 2C) or were "intermediate type," with irregularly shaped nuclei ( Figure 2D ). The cells frequently appeared to be linked to each other and to adjacent unlabeled epithelia by desmosomes ( Figure 2C) .
No labeled cells at either the light or the electron microscopic 1eve.l were found in negative control sections (not shown). In situ hybridization studies revealed positive reactivity for GH mRNA in cells distributed beneath the thymic capsule ( Figure 3A ) and along the septa ( Figure 3B) . Apart from the similar localization, the number of cells expressing GH mRNA was less than the number of GH-immunoreactive cells. This could be due to the fact that, at the time of sampling, the cells synthesizing GH represented only a part of the cells containing GH already synthesized. At higher magnification, the label appeared to idenufy cytoplasmic process that adhered to adjacent lymphoid cells ( Figures 3C and 3D ). Treatment with RNAse resulted in a total loss of cell positivity, indicating that the probe was actually recognizing RNA chains (Figure 3E) .
DiscusSion
In the present study we demonstrated by both immunohistochemisuy and in situ hybridization the presence of distinct epithelial cell subsets producing a GH-like substance in the human thymus.
Previous work has documented the presence of both Pit-VGHF-1 mRNA and Pit-lIGHFl protein in human thymic non-lymphoid cells (4). Since Pit-l/GHFl transcription factor controls GH and PRL expression in pituitary cells, it appears that this factor can also control the expression of GH and PRL in human thymus. Interestingly, Pit-lIGHF-l-expressing cells were located in the subcapsular area of the thymus in the same compartment in which we found epithelial cells positive for the presence of GH mRNA dnd GHimmunoreactive substance. However, Pit-lIGHFl is also expressed in cells at the corticomedullary junction and the medulla (4), where we did not find GH-expressing cells. This discrepancy could be due to the fact that Pit-1IGHF-1 in the corticomedullary junction and medulla are actually producing only PRL. It must be noted that the anti-GH antibody used in this study did not crossreact with PRL, and in situ hybridization did not reveal any signal for GH mRNA transcripts in the above compartments. Weigent and Blalock (1) found that mononuclear leukocytes isolated from the thymus synthesize and release GH. We did not find any positivity in thymocytes either by immunocytckhemistry or by in situ hybridization. This discrepancy could be due to the fact that appreciable amounts of GH mRNA become detectable in isolated thymocytes only after 24 hr of culture, and we assayed only freshly prepared thymocytes.
It has been shown that the subcapsular cortex of human thymus contains neuropeptide-immunoreactive epithelial cells (11) . This finding, together with the observation of GH-producing cells in this area, suggests that these hormones may act as lymphoid growth and differentiation factors. In fact, this microenvironment contains T-lymphocyte progenitors recently migrated into the thymus (17) . The subcapsular-perivascular region, demarcated by the Type 1 epithelium, is arguably one of the most important in the thymus, as it initiates thymopoiesis and produces most, ifnot all, of the known thymic hormones (18) . In this respect, it was interesting to find that plasma thymulin levels were decreased in GHdeficient boys and that a single GH dose restored plasma thymulin levels (19) .
Type 2 epithelium appears metabolically very active, presumably producing cytokines, which are very important in regulating the thymic microenvironment (18) . Local concentrations of GH higher than systemic concentrations and combination with other factors may be required for specific effects. The peculiar perivascular location of GH-expressing cells in the thymic septa suggests that this hormone could enter the microvasculature and thus become available to the thymic parenchyma.
